send to a friend by email

JPH reports net income of $1.91 million in 9M 2017

2017-11-01

According to the financial statements of  Jerusalem Pharmaceuticals JPH for the first nine months of 2017, Net profit after tax of the period reached 4,301,803 USD Compared with Net profit after tax 1,916,996 USD for 2016, a net increase in profit of 124.40%.Total assets of the company reached 60,808,624 USD compared with total assets of 52,970,017 USD at the end of year 2016, a net increase of 14.80%.Total liabilities of the company reached 15,226,263 USD compared with total liabilities of 12,709,989 USD at the end of year 2016, a net increase of 19.79%. Net ownership equity of the company reached 45,582,361 USD (Including Non-Controlling Interests of 525,788 USD) compared with total owner equity of 40,260,028 USD (Including Non-Controlling Interests of 526,771 USD) at the end of year 2016, a net increase of 13.22%.